Sort
10,766 grants matching “checkpoint inhibitor”
Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis
$591,007Efstathios Karathanasis · Case Western Reserve University · R01 · FY2020 · CA
Pathology Core
$590,984Geoffrey I Shapiro · Dana-Farber Cancer Inst · P01 · FY2025 · CA
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis
$590,958Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2022 · CA
preclinical optimization of BCMA directed T cell therapy
$590,784Marta Chesi · Mayo Clinic Arizona · R01 · FY2024 · CA
Post-Initiation control of transcription in inflammatory macrophages
$590,756Inez Rogatsky · Hospital For Special Surgery · R01 · FY2023 · AI
Post-Initiation control of transcription in inflammatory macrophages
$590,756Inez Rogatsky · Hospital For Special Surgery · R01 · FY2022 · AI
Post-Initiation control of transcription in inflammatory macrophages
$590,756Inez Rogatsky · Hospital For Special Surgery · R01 · FY2024 · AI
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$590,346Cristian T Badea · Duke University · U24 · FY2019 · CA
Administrative Core
$590,179Jun Yan · University Of Louisville · P20 · FY2024 · GM
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$590,123Lei Zheng · Johns Hopkins University · R01 · FY2019 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$590,100Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2023 · CA
Optimization of an active mutant KRAS peptide vaccine in colorectal cancer
$589,838Nilofer S. Azad · Johns Hopkins University · R01 · FY2025 · CA
Neoadjuvant immunoradiotherapy for HPV mediated oropharynx cancer
$589,762Joseph A Califano · University Of California, San Diego · R01 · FY2024 · CA
Rational approaches to melanoma therapy
$589,729Meenhard Herlyn · Wistar Institute · U54 · FY2022 · CA
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
$589,164Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Finding the optimal balance of immunotherapy efficacy and toxicity.
$589,033David Eric Gerber · Ut Southwestern Medical Center · U01 · FY2020 · AI
Credentialing Mouse Models for Immune System Therapy Research
$588,966Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA
Glycosylation and Immune Evasion in Urologic Tumors
$588,870Sharon Pitteri · Stanford University · U01 · FY2022 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion
$588,394Ioannis Vlachos · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$588,065Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Novel Approaches Targeting B7-H3 in Castration-resistant Prostate Cancer
$588,065Di Zhao · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Molecular Digital CytoImaging for Leukemia Drug Screening
$587,933Tothu Q Vu · Oregon Health & Science University · R01 · FY2020 · CA
Molecular Targeting of Diffuse Large B-cell Lymphoma
$587,846Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · CA
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
$587,495Khandan Keyomarsi · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Using the IL-1R1 and its ligands to optimize the T cell immune response to cancer
$587,394Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2024 · CA